Correlation Between Vaccinex and Mesoblast
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Mesoblast at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Mesoblast into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Mesoblast, you can compare the effects of market volatilities on Vaccinex and Mesoblast and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Mesoblast. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Mesoblast.
Diversification Opportunities for Vaccinex and Mesoblast
Pay attention - limited upside
The 3 months correlation between Vaccinex and Mesoblast is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Mesoblast in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mesoblast and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Mesoblast. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mesoblast has no effect on the direction of Vaccinex i.e., Vaccinex and Mesoblast go up and down completely randomly.
Pair Corralation between Vaccinex and Mesoblast
If you would invest (100.00) in Vaccinex on December 30, 2024 and sell it today you would earn a total of 100.00 from holding Vaccinex or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Vaccinex vs. Mesoblast
Performance |
Timeline |
Vaccinex |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Mesoblast |
Vaccinex and Mesoblast Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vaccinex and Mesoblast
The main advantage of trading using opposite Vaccinex and Mesoblast positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Mesoblast can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mesoblast will offset losses from the drop in Mesoblast's long position.Vaccinex vs. Protara Therapeutics | Vaccinex vs. Monopar Therapeutics | Vaccinex vs. Surrozen | Vaccinex vs. Salarius Pharmaceuticals |
Mesoblast vs. Aditxt Inc | Mesoblast vs. Lipocine | Mesoblast vs. Connect Biopharma Holdings | Mesoblast vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |